These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 2509916)

  • 1. Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial.
    Davis GL; Balart LA; Schiff ER; Lindsay K; Bodenheimer HC; Perrillo RP; Carey W; Jacobson IM; Payne J; Dienstag JL;
    N Engl J Med; 1989 Nov; 321(22):1501-6. PubMed ID: 2509916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of chronic hepatitis C with recombinant alpha-interferon. A multicentre randomized, controlled trial. The Hepatitis Interventional Therapy Group.
    Davis GL; Balart LA; Schiff ER; Lindsay K; Bodenheimer HC; Perrillo RP; Carey W; Jacobson IM; Payne J; Dienstag JL
    J Hepatol; 1990; 11 Suppl 1():S31-5. PubMed ID: 2127785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of chronic hepatitis D with interferon alfa-2a.
    Farci P; Mandas A; Coiana A; Lai ME; Desmet V; Van Eyken P; Gibo Y; Caruso L; Scaccabarozzi S; Criscuolo D
    N Engl J Med; 1994 Jan; 330(2):88-94. PubMed ID: 8259188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group.
    Perrillo RP; Schiff ER; Davis GL; Bodenheimer HC; Lindsay K; Payne J; Dienstag JL; O'Brien C; Tamburro C; Jacobson IM; Sampliner R; Feit D; Lefkowitch J; Kuhns M; Meschievitz C; Sanghvi B; Albrecht J; Gibas A;
    N Engl J Med; 1990 Aug; 323(5):295-301. PubMed ID: 2195346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group.
    Poynard T; Bedossa P; Chevallier M; Mathurin P; Lemonnier C; Trepo C; Couzigou P; Payen JL; Sajus M; Costa JM
    N Engl J Med; 1995 Jun; 332(22):1457-62. PubMed ID: 7739681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multi-center, randomized, double-blind, placebo-controlled trial. Leich Study Group.
    Niederau C; Strohmeyer G; Heintges T; Peter K; Göpfert E
    Hepatogastroenterology; 1998; 45(21):797-804. PubMed ID: 9684137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy of hepatitis C: consensus interferon trials. Consensus Interferon Study Group.
    Keeffe EB; Hollinger FB
    Hepatology; 1997 Sep; 26(3 Suppl 1):101S-107S. PubMed ID: 9305673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial of interferon alfa-2b as therapy for chronic non-A, non-B hepatitis.
    Saracco G; Rosina F; Torrani Cerenzia MR; Lattore V; Chiandussi L; Gallo V; Petrino R; De Micheli AG; Donegani E; Solinas A
    J Hepatol; 1990; 11 Suppl 1():S43-9. PubMed ID: 2127787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates. Results of the first multicentre Australian trial. Australia Hepatitis C Study Group.
    Lin R; Roach E; Zimmerman M; Strasser S; Farrell GC
    J Hepatol; 1995 Nov; 23(5):487-96. PubMed ID: 8583134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.
    Davis GL; Esteban-Mur R; Rustgi V; Hoefs J; Gordon SC; Trepo C; Shiffman ML; Zeuzem S; Craxi A; Ling MH; Albrecht J
    N Engl J Med; 1998 Nov; 339(21):1493-9. PubMed ID: 9819447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.
    Di Bisceglie AM; Martin P; Kassianides C; Lisker-Melman M; Murray L; Waggoner J; Goodman Z; Banks SM; Hoofnagle JH
    N Engl J Med; 1989 Nov; 321(22):1506-10. PubMed ID: 2509917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study of recombinant human alpha-interferon for chronic non-A, non-B hepatitis.
    Kakumu S; Arao M; Yoshioka K; Ichimiya H; Murase K; Aoi T; Kusakabe A
    Am J Gastroenterol; 1989 Jan; 84(1):40-5. PubMed ID: 2521421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis.
    Heathcote EJ; Shiffman ML; Cooksley WG; Dusheiko GM; Lee SS; Balart L; Reindollar R; Reddy RK; Wright TL; Lin A; Hoffman J; De Pamphilis J
    N Engl J Med; 2000 Dec; 343(23):1673-80. PubMed ID: 11106716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: a randomized multicenter trial. Hepatitis Interventional Therapy Group.
    Lindsay KL; Davis GL; Schiff ER; Bodenheimer HC; Balart LA; Dienstag JL; Perrillo RP; Tamburro CH; Goff JS; Everson GT; Silva M; Katkov WN; Goodman Z; Lau JY; Maertens G; Gogate J; Sanghvi B; Albrecht J
    Hepatology; 1996 Nov; 24(5):1034-40. PubMed ID: 8903371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: a multicenter, controlled, randomized trial. Le Groupe D'étude et De Traitement du Virus De L'hépatite C (Get.Vhc).
    Payen JL; Izopet J; Galindo-Migeot V; Lauwers-Cances V; Zarski JP; Seigneurin JM; Dussaix E; Voigt JJ; Selves J; Barange K; Puel J; Pascal JP
    Hepatology; 1998 Dec; 28(6):1680-6. PubMed ID: 9828235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term response to therapy of chronic anti-HBe-positive hepatitis B is poor independent of type and schedule of interferon.
    Oliveri F; Santantonio T; Bellati G; Colombatto P; Mels GC; Carriero L; Dastoli G; Pastore G; Ideo G; Bonino F; Brunetto MR
    Am J Gastroenterol; 1999 May; 94(5):1366-72. PubMed ID: 10235220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, double-blind, placebo-controlled trial of eight-week course of recombinant alpha-interferon for chronic non-A, non-B hepatitis.
    Omata M; Ito Y; Yokosuka O; Imazeki F; Tagawa M; Takano S; Hosoda K; Tada M; Ohto M; Ito K
    Dig Dis Sci; 1991 Sep; 36(9):1217-22. PubMed ID: 1654240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant interferon-alpha and ursodeoxycholic acid versus interferon-alpha alone in the treatment of chronic hepatitis C: a randomized clinical trial with long-term follow-up.
    Angelico M; Gandin C; Pescarmona E; Rapicetta M; Del Vecchio C; Bini A; Spada E; Baroni CD; Capocaccia L
    Am J Gastroenterol; 1995 Feb; 90(2):263-9. PubMed ID: 7847298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peginterferon alfa-2a in patients with chronic hepatitis C.
    Zeuzem S; Feinman SV; Rasenack J; Heathcote EJ; Lai MY; Gane E; O'Grady J; Reichen J; Diago M; Lin A; Hoffman J; Brunda MJ
    N Engl J Med; 2000 Dec; 343(23):1666-72. PubMed ID: 11106715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized controlled trial of recombinant interferon-alpha 2b in the treatment of Chinese patients with chronic hepatitis C.
    Hwang SJ; Chan CY; Lu RH; Wu JC; Lee SD
    J Interferon Cytokine Res; 1995 Jul; 15(7):611-6. PubMed ID: 7553231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.